About
Spencer Kroll, MD, PhD, FACP, FNLA, is a board-certified internist and nationally recognized lipidology expert based in Morganville, NJ. He earned his Bachelor of Science in Biology from Cornell University before completing his medical degree at George Washington University School of Medicine. His internship and residency in Internal Medicine took place at Georgetown University Medical Center, where he later served on the clinical faculty. Prior to medical school, Dr. Kroll trained as a Howard Hughes Scholar at Mount Sinai School of Medicine, earning a PhD in Pharmacology and Toxicology and a Master's in Biostatistics from CUNY/Mount Sinai. He also holds a Certification in Toxicology from Johns Hopkins University and is a member of the American Academy of Clinical Toxicology.
Dr. Kroll holds board certification in Internal Medicine and certification from the American Board of Clinical Lipidology. He serves as a Fellow of both the National Lipid Association and the American College of Physicians. New Jersey Top Doctors has recognized him every year from 2011 through 2025. He currently serves as a clinical instructor at the University of Southern California. His clinical focus includes statin intolerance, Lp(a) management, familial hypercholesterolemia, PCSK9 inhibitor therapy, and cardiovascular genetic testing. Dr. Kroll has served as principal investigator on multiple clinical trials and has authored numerous peer-reviewed articles. He co-authored two books, "The Ozempic Diet" and "The Ultimate Semaglutide Handbook," and contributes to Sharecare representing the National Lipid Association. He also performs independent medical evaluations, permanency assessments, and expert reviews in personal injury and workers' compensation matters through Medical-Legal Evaluations PA of New Jersey.
Education & Training
Undergraduate
Cornell University, B.S. Biology
Medical School
George Washington University School of Medicine
Residency
Internal Medicine, Georgetown University Medical Center
Additional Training
PhD in Pharmacology and Toxicology, CUNY/Mount Sinai School of Medicine; Master's in Biostatistics, CUNY/Mount Sinai School of Medicine; Certification in Toxicology, Johns Hopkins University; Howard Hughes Scholar at Mount Sinai School of Medicine; Clinical instructor, University of Southern California; Former medical instructor, Georgetown University
Certifications
Conditions Treated
Who is Dr. Kroll right for?
Dr. Kroll is a strong fit for adults managing complex cholesterol conditions, including familial hypercholesterolemia, elevated Lp(a), and statin intolerance. Patients referred by cardiologists or endocrinologists for advanced lipid evaluation find his subspecialty depth particularly useful. He also serves adults seeking comprehensive primary care with a preventive and integrative focus. Patients managing chronic conditions such as diabetes, hypertension, metabolic syndrome, or thyroid disease benefit from his broad internal medicine background. Those interested in executive health or concierge-level access will find a direct-access option available through the practice.
Similar Doctors Nearby
Dr. Tariq RizviMD
Internal Medicinehypertension, cardiovascular disease, preventive health +1 more
Dr. Scott YagerMD
Internal Medicinestress-related conditions, hypertension, cardiovascular disease prevention +3 more
Dr. Catherine SchianoDO
Family Medicinecancer (preventive screening), preventive health, high blood pressure +13 more
Frequently Asked Questions
Dr. Kroll specializes in complex lipid disorders, including familial hypercholesterolemia, elevated Lp(a), hypertriglyceridemia, statin intolerance, and atherosclerosis. He also treats a broad range of internal medicine conditions such as diabetes, hypertension, metabolic syndrome, thyroid disease, and cardiovascular disease. His clinical work spans preventive medicine, pharmacology, and drug interaction management.
Yes. Dr. Kroll holds certification from the American Board of Clinical Lipidology and is a Fellow of the National Lipid Association. He also holds board certification in Internal Medicine and a Certification in Toxicology from Johns Hopkins University.
Dr. Kroll earned his medical degree from George Washington University School of Medicine and completed his Internal Medicine residency at Georgetown University Medical Center. Before medical school, he earned a PhD in Pharmacology and Toxicology and a Master's in Biostatistics from CUNY/Mount Sinai School of Medicine as a Howard Hughes Scholar.
New Jersey Top Doctors has named Dr. Kroll every year from 2011 through 2025. National media outlets including Forbes, WebMD, Medical News Today, and the Huffington Post have featured him as an expert. He also contributes to Sharecare as a representative of the National Lipid Association.
Yes. Dr. Kroll has served as a principal investigator on multiple clinical trials. He has authored numerous peer-reviewed research articles and stays at the forefront of research on advanced lipid-lowering therapies, including PCSK9 inhibitors.
Dr. Kroll has extensive experience prescribing PCSK9 inhibitors and navigating insurance and Medicare approval for these medications. He evaluates each patient's cardiovascular risk profile individually and uses advanced lipid testing to determine whether PCSK9 inhibitor therapy is appropriate.
Yes. Dr. Kroll performs independent medical evaluations, permanency assessments, and expert reviews through Medical-Legal Evaluations PA of New Jersey. His work covers internal organ injuries, toxicology, environmental exposure, and cancer risk assessments in personal injury and workers' compensation matters.
Yes. Dr. Kroll founded one of the only statin intolerance centers in the United States. He evaluates genetic and pharmacological factors that affect statin tolerability and works with patients to identify effective alternatives or adjustments to their cholesterol treatment.
Dr. Kroll offers a comprehensive advanced lipid testing panel that includes ApoB, LDL-particle number, Lp(a), ApoA1, sdLDL, and cardiovascular genetic testing. The practice also performs non-invasive carotid intima-media thickness imaging to assess plaque buildup directly.
Doctor profile last updated June 11, 2026